Stock PBSV PHARMA-BIO SERV, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharma-Bio Serv, Inc.

Equities

PBSV

US71711N1000

Business Support Services

Market Closed - OTC Markets
Other stock markets
 01:28:39 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.735 USD +5.00% Intraday chart for Pharma-Bio Serv, Inc. -8.12% -30.00%
Mar. 18 Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Jan. 30 Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024 CI

Valuation

Fiscal Period: Oktober 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 20.12 29.67 23.72 19.73 19.51 16.88 -
Enterprise Value (EV) 1 20.12 29.67 23.72 19.73 19.51 16.88 16.88
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue 1.03 x 1.38 x 1.18 x 1.02 x 1.15 x 1.32 x 0.84 x
EV / Revenue 1.03 x 1.38 x 1.18 x 1.02 x 1.15 x 1.32 x 0.84 x
EV / EBITDA - - -6,273,546 x - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 22,996 23,002 23,029 22,944 22,963 22,961 -
Reference price 2 0.8750 1.290 1.030 0.8600 0.8497 0.7350 0.7350
Announcement Date 1/29/20 2/1/21 2/11/22 1/30/23 1/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober 2019 2020 2021 2022 2023 2024 2025
Net sales 1 19.51 21.56 20.12 19.4 16.98 12.8 20.2
EBITDA - - -3.781 - - - -
EBIT 1.697 - -3.854 - - - -
Operating Margin 8.7% - -19.16% - - - -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 1/29/20 2/1/21 2/11/22 1/30/23 1/29/24 - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: October 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4.238 4.563 4.577 3.598 - 3 3.5 4 5 5
EBITDA - - - - - - - - - -
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - -0.2707 - - - - -
Net margin - - - - - - - - - -
EPS - - - - -0.0120 - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 3/17/23 6/14/23 9/14/23 1/29/24 3/18/24 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - 0.01 - - - -
Capex / Sales - - 0.05% - - - -
Announcement Date 1/29/20 2/1/21 2/11/22 1/30/23 1/29/24 - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Management Consulting Services

1st Jan change Capi.
PHARMA-BIO SERV, INC. Stock Pharma-Bio Serv, Inc.
-30.00% 16.88M
FTI CONSULTING, INC. Stock FTI Consulting, Inc.
+6.13% 7.41B
BAYCURRENT CONSULTING, INC. Stock BayCurrent Consulting, Inc.
-32.64% 3.24B
NIHON M&A CENTER HOLDINGS INC. Stock Nihon M&A Center Holdings Inc.
+11.38% 1.75B
SHANGHAI RESEARCH INSTITUTE OF BUILDING SCIENCES GROUP CO., LTD. Stock Shanghai Research Institute of Building Sciences Group Co., Ltd.
-9.32% 1.08B
ANHUI TRANSPORT CONSULTING & DESIGN INSTITUTE CO.,LTD. Stock Anhui Transport Consulting & Design Institute Co.,Ltd.
+31.69% 907M
FUNAI SOKEN HOLDINGS INCORPORATED Stock Funai Soken Holdings Incorporated
-7.64% 714M
THE HACKETT GROUP, INC. Stock The Hackett Group, Inc.
-3.60% 606M
STRIKE COMPANY,LIMITED Stock Strike Company,Limited
-8.30% 539M
DARK HORSE TECHNOLOGY GROUP CO., LTD. Stock Dark Horse Technology Group Co., Ltd.
-22.29% 515M
Management Consulting Services
  1. Stock Market
  2. Equities
  3. PBSV Stock
  4. Financials Pharma-Bio Serv, Inc.